ARGAN INC·4

Jun 12, 4:30 PM ET

Flanders Cynthia 4

Research Summary

AI-generated summary

Updated

Argan (AGX) Director Cynthia Flanders Exercises Derivatives and Gifts Shares

What Happened

  • Cynthia Flanders, a director of Argan, Inc. (AGX), made multiple transactions on June 10, 2026. She made a bona fide gift of 1,000 common shares (disposition), exercised/converted derivatives resulting in the acquisition of 533 shares and the disposition of 530 derivative shares, and was granted 189 Time‑Based Restricted Stock Units (TRSUs). All transactions reported a $0 cash price/consideration.

Key Details

  • Transaction date: June 10, 2026; Form 4 filed June 12, 2026 (timely — within 2 business days).
  • Reported prices/consideration: $0 for all items (stock settlement/vesting/gift).
  • Shares owned after the transactions: not specified in the provided filing.
  • Footnotes: F1 confirms the 1,000‑share gift; F2 states 530 shares became issuable under a one‑year vesting schedule for prior TRSUs (adjusted for dividends); F3 documents the June 10, 2026 grant of 189 TRSUs that vest fully on June 10, 2027 or at the 2027 Annual Meeting, whichever is earlier.
  • Filing timeliness: Filed two days after the transaction date — appears timely.

Context

  • Gift transactions are dispositions but do not necessarily indicate a view on the company’s prospects.
  • The derivative entries reflect vesting/conversion of restricted units or similar instruments (stock‑settled rather than a cash exercise). The new TRSU grant will vest over the coming year per the stated schedule.
  • No indication this is a 10% owner transaction; filings are routine for director compensation and vesting events.